Stock Analysis

Asian Growth Companies With High Insider Ownership To Watch

As Asian markets navigate a landscape marked by economic uncertainties and shifting monetary policies, investors are keenly observing the performance of regional equities. Amidst this backdrop, growth companies with high insider ownership stand out as potential opportunities, offering a combination of strategic vision and vested interest that can be appealing in times of market volatility.

Top 10 Growth Companies With High Insider Ownership In Asia

NameInsider OwnershipEarnings Growth
Techwing (KOSDAQ:A089030)19.1%64.4%
Suzhou Sunmun Technology (SZSE:300522)35.4%84.7%
Samyang Foods (KOSE:A003230)11.7%28.3%
Oscotec (KOSDAQ:A039200)12.7%104.1%
Novoray (SHSE:688300)23.6%28.4%
M31 Technology (TPEX:6643)30.7%96.8%
Laopu Gold (SEHK:6181)35.5%34.3%
Gold Circuit Electronics (TWSE:2368)31.4%35.2%
Fulin Precision (SZSE:300432)11.8%48.5%
Ascentage Pharma Group International (SEHK:6855)12.7%91.9%

Click here to see the full list of 604 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

Beijing Konruns PharmaceuticalLtd (SHSE:603590)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Beijing Konruns Pharmaceutical Co., Ltd. is involved in the research, development, production, and sale of pharmaceuticals both in China and internationally, with a market cap of CN¥9.84 billion.

Operations: The company generates revenue from its Pharmaceutical Manufacturing segment, amounting to CN¥838.16 million.

Insider Ownership: 32.3%

Revenue Growth Forecast: 26% p.a.

Beijing Konruns Pharmaceutical Ltd. has demonstrated growth with recent half-year earnings showing an increase in sales to CNY 460.87 million and net income rising to CNY 91.05 million. Despite a volatile share price and low profit margins, the company is forecasted for significant revenue growth at 26% annually, outpacing the Chinese market's average. However, return on equity is expected to be low at 5.7%, raising concerns about future profitability sustainability despite high insider ownership levels.

SHSE:603590 Earnings and Revenue Growth as at Sep 2025
SHSE:603590 Earnings and Revenue Growth as at Sep 2025

WG TECH (Jiang Xi) (SHSE:603773)

Simply Wall St Growth Rating: ★★★★★★

Overview: WG TECH (Jiang Xi) Co., Ltd. operates in China, offering glass-based circuit boards and related electronic devices, with a market cap of CN¥8.42 billion.

Operations: The company generates revenue from its optoelectronics segment, amounting to CN¥2.24 billion.

Insider Ownership: 28.9%

Revenue Growth Forecast: 30.4% p.a.

WG TECH (Jiang Xi) is expected to achieve profitability within three years, with anticipated annual earnings growth of 102.65%, surpassing the Chinese market average. Revenue is projected to grow at 30.4% per year, significantly outpacing the market's 13.7%. Despite high return on equity forecasts and trading at a good relative value, its financial position is weakened by debt not well-covered by operating cash flow and recent share price volatility may pose risks for investors.

SHSE:603773 Earnings and Revenue Growth as at Sep 2025
SHSE:603773 Earnings and Revenue Growth as at Sep 2025

Jiangsu Gian Technology (SZSE:300709)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Jiangsu Gian Technology Co., Ltd. manufactures and sells metal injection molding products both in China and internationally, with a market cap of CN¥10.74 billion.

Operations: Jiangsu Gian Technology generates revenue from the manufacture and sale of metal injection molding products domestically and abroad.

Insider Ownership: 27.5%

Revenue Growth Forecast: 14.0% p.a.

Jiangsu Gian Technology's insider ownership aligns with its strategic growth trajectory, as evidenced by recent amendments to its articles of association and business scope expansion. The company's earnings are forecasted to grow significantly at 26.3% annually, outpacing the Chinese market average. However, revenue growth is slower than desired at 14% per year. The recent CNY 580 million convertible bond issuance indicates proactive capital management but may introduce financial complexities alongside low projected return on equity of 8.4%.

SZSE:300709 Ownership Breakdown as at Sep 2025
SZSE:300709 Ownership Breakdown as at Sep 2025

Next Steps

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

The New Payments ETF Is Live on NASDAQ:

Money is moving to real-time rails, and a newly listed ETF now gives investors direct exposure. Fast settlement. Institutional custody. Simple access.

Explore how this launch could reshape portfolios

Sponsored Content

Valuation is complex, but we're here to simplify it.

Discover if Beijing Konruns PharmaceuticalLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About SHSE:603590

Beijing Konruns PharmaceuticalLtd

Engages in the research and development, production, and sale of pharmaceuticals in China and internationally.

High growth potential with excellent balance sheet.

Weekly Picks

AL
RKLB logo
AlexLovell on Rocket Lab ·

Early mover in a fast growing industry. Likely to experience share price volatility as they scale

Fair Value:US$16.25375.0% overvalued
44 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
AG
Agricola
EXN logo
Agricola on Excellon Resources ·

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.4% undervalued
50 users have followed this narrative
7 users have commented on this narrative
15 users have liked this narrative
FU
FundamentallySarcastic
CCP logo
FundamentallySarcastic on Credit Corp Group ·

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08

Fair Value:AU$12.6411.4% overvalued
8 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative

Updated Narratives

YI
META logo
yiannisz on Meta Platforms ·

Meta’s Bold Bet on AI Pays Off

Fair Value:US$723.118.0% undervalued
33 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
YI
ADP logo
yiannisz on Automatic Data Processing ·

ADP Stock: Solid Fundamentals, But AI Investments Test Its Margin Resilience

Fair Value:US$387.7733.7% undervalued
14 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
YI
V logo
yiannisz on Visa ·

Visa Stock: The Toll Booth at the Center of Global Commerce

Fair Value:US$429.7317.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8684.9% undervalued
83 users have followed this narrative
8 users have commented on this narrative
23 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3924.4% undervalued
981 users have followed this narrative
6 users have commented on this narrative
26 users have liked this narrative
RO
RobertoAllende
NVDA logo
RobertoAllende on NVIDIA ·

The AI Infrastructure Giant Grows Into Its Valuation

Fair Value:US$345.0745.2% undervalued
44 users have followed this narrative
28 users have commented on this narrative
24 users have liked this narrative